{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28687730", "DateCompleted": {"Year": "2019", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "07", "Day": "07"}], "Language": ["eng"], "ELocationID": ["4923", "10.1038/s41598-017-04968-z"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "7", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Jul", "Day": "07"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Fluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model of multiple sclerosis.", "Pagination": {"StartPage": "4923", "MedlinePgn": "4923"}, "Abstract": {"AbstractText": ["Multiple Sclerosis (MS) require medications controlling severity of the pathology and depression, affecting more than half of the patients. In this study, the effect of antidepressant drug fluvoxamine, a selective serotonin reuptake inhibitor, was investigated in vitro and in vivo. Nanomolar concentrations of fluvoxamine significantly increased cell viability and proliferation of neural stem cells (NSCs) through increasing mRNA expression of Notch1, Hes1 and Ki-67, and protein levels of NICD. Also, physiological concentrations of fluvoxamine were optimal for NSC differentiation toward oligodendrocytes, astrocytes and neurons. In addition, fluvoxamine attenuated experimental autoimmune encephalomyelitis (EAE) severity, a rat MS model, by significantly decreasing its clinical scores. Moreover, fluvoxamine treated EAE rats showed a decrease in IFN-\u03b3 serum levels and an increase in IL-4, pro- and anti-inflammatory cytokines respectively, compared to untreated EAE rats. Furthermore, immune cell infiltration and demyelination plaque significantly decreased in spinal cords of fluvoxamine-treated rats, which was accompanied by an increase in protein expression of MBP and GFAP positive cells and a decrease in lactate serum levels, a new biomarker of MS progression. In summary, besides its antidepressant activity, fluvoxamine stimulates proliferation and differentiation of NSCs particularly toward oligodendrocytes, a producer of CNS myelin."]}, "AuthorList": [{"Identifier": ["0000-0003-2344-3640"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Ghareghani", "ForeName": "Majid", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "ER045, Laboratory of stem cells, PRASE, Biology department, Faculty of Sciences-I, Lebanese University, Beirut, Lebanon."}], "LastName": "Zibara", "ForeName": "Kazem", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Sadeghi", "ForeName": "Heibatollah", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Dokoohaki", "ForeName": "Shima", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Sadeghi", "ForeName": "Hossein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Aryanpour", "ForeName": "Roya", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran. amirghanbari52@yahoo.com."}], "LastName": "Ghanbari", "ForeName": "Amir", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "GFAP protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Glial Fibrillary Acidic Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Hes1 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunologic Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Ki-67 Antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "Myelin Basic Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Notch1 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptor, Notch1"}, {"RegistryNumber": "0", "NameOfSubstance": "Serotonin Uptake Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factor HES-1"}, {"RegistryNumber": "207137-56-2", "NameOfSubstance": "Interleukin-4"}, {"RegistryNumber": "82115-62-6", "NameOfSubstance": "Interferon-gamma"}, {"RegistryNumber": "O4L1XPO44W", "NameOfSubstance": "Fluvoxamine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Astrocytes"}, {"QualifierName": [], "DescriptorName": "Cell Differentiation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Embryo, Mammalian"}, {"QualifierName": ["drug therapy", "genetics", "immunology", "pathology"], "DescriptorName": "Encephalomyelitis, Autoimmune, Experimental"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Fluvoxamine"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Glial Fibrillary Acidic Protein"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Immunologic Factors"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Interferon-gamma"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Interleukin-4"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Ki-67 Antigen"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Myelin Basic Protein"}, {"QualifierName": ["drug effects", "immunology", "pathology"], "DescriptorName": "Neural Stem Cells"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Neurons"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Oligodendroglia"}, {"QualifierName": [], "DescriptorName": "Primary Cell Culture"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Inbred Lew"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Receptor, Notch1"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Selective Serotonin Reuptake Inhibitors"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Transcription Factor HES-1"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hagemeier K, Bruck W, Kuhlmann T. Multiple sclerosis - remyelination failure as a cause of disease progression. Histol Histopathol. 2012;27:277\u2013287.", "ArticleIdList": ["22237705"]}, {"Citation": "Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology. 2003;61:1524\u20131527. doi: 10.1212/01.WNL.0000095964.34294.B4.", "ArticleIdList": ["10.1212/01.WNL.0000095964.34294.B4", "14663036"]}, {"Citation": "Mohr DC, Hart SL, Fonareva I, Tasch ES. Treatment of depression for patients with multiple sclerosis in neurology clinics. Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12:204\u2013208. doi: 10.1191/135248506ms1265oa.", "ArticleIdList": ["10.1191/135248506ms1265oa", "16629424"]}, {"Citation": "Vattakatuchery JJ, Rickards H, Cavanna AE. Pathogenic mechanisms of depression in multiple sclerosis. The Journal of neuropsychiatry and clinical neurosciences. 2011;23:261\u2013276. doi: 10.1176/jnp.23.3.jnp261.", "ArticleIdList": ["10.1176/jnp.23.3.jnp261", "21948887"]}, {"Citation": "Abdel-Salam OM, Safaa MYM, Amany AS. The effect of different antidepressant drugs on oxidative stress after lipopolysaccharide administration in mice. EXCLI Journal. 2011;10:290\u2013302.", "ArticleIdList": ["PMC5611632", "29033710"]}, {"Citation": "Perez LP, Gonzalez RS, Lazaro EB. Treatment of mood disorders in multiple sclerosis. Current treatment options in neurology. 2015;17:323. doi: 10.1007/s11940-014-0323-4.", "ArticleIdList": ["10.1007/s11940-014-0323-4", "25398464"]}, {"Citation": "Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. The American journal of psychiatry. 1990;147:1493\u20131497. doi: 10.1176/ajp.147.11.1562.", "ArticleIdList": ["10.1176/ajp.147.11.1562", "2221162"]}, {"Citation": "Benedetti F, Campori E, Colombo C, Smeraldi E. Fluvoxamine treatment of major depression associated with multiple sclerosis. The Journal of neuropsychiatry and clinical neurosciences. 2004;16:364\u2013366. doi: 10.1176/jnp.16.3.364.", "ArticleIdList": ["10.1176/jnp.16.3.364", "15377746"]}, {"Citation": "Ehde DM, et al. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. General hospital psychiatry. 2008;30:40\u201348. doi: 10.1016/j.genhosppsych.2007.08.002.", "ArticleIdList": ["10.1016/j.genhosppsych.2007.08.002", "18164939"]}, {"Citation": "Solaro C, et al. Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study. Clinical neuropharmacology. 2013;36:114\u2013116. doi: 10.1097/WNF.0b013e3182996400.", "ArticleIdList": ["10.1097/WNF.0b013e3182996400", "23783007"]}, {"Citation": "Yuan XQ, et al. Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats. Neuroimmunomodulation. 2012;19:201\u2013208. doi: 10.1159/000334095.", "ArticleIdList": ["10.1159/000334095", "22441536"]}, {"Citation": "Taler M, Gil-Ad I, Korob I, Weizman A. The immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Neuroimmunomodulation. 2011;18:117\u2013122. doi: 10.1159/000321634.", "ArticleIdList": ["10.1159/000321634", "21088435"]}, {"Citation": "Bayas A, Schuh K, Baier M, Vormfelde SV. Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN. Therapeutic advances in neurological disorders. 2016;9:378\u2013388. doi: 10.1177/1756285616651197.", "ArticleIdList": ["10.1177/1756285616651197", "PMC4994781", "27582893"]}, {"Citation": "Kusakawa S, et al. Fluoxetine promotes gliogenesis during neural differentiation in mouse embryonic stem cells. J Neurosci Res. 2010;88:3479\u20133487. doi: 10.1002/jnr.22509.", "ArticleIdList": ["10.1002/jnr.22509", "20857517"]}, {"Citation": "Tamm C, Duckworth J, Hermanson O, Ceccatelli S. High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. Journal of neurochemistry. 2006;97:69\u201378. doi: 10.1111/j.1471-4159.2006.03718.x.", "ArticleIdList": ["10.1111/j.1471-4159.2006.03718.x", "16524380"]}, {"Citation": "Gage FH. Mammalian neural stem cells. Science (New York, NY) 2000;287:1433\u20131438. doi: 10.1126/science.287.5457.1433.", "ArticleIdList": ["10.1126/science.287.5457.1433", "10688783"]}, {"Citation": "Kageyama R, Ohtsuka T, Hatakeyama J, Ohsawa R. Roles of bHLH genes in neural stem cell differentiation. Experimental cell research. 2005;306:343\u2013348. doi: 10.1016/j.yexcr.2005.03.015.", "ArticleIdList": ["10.1016/j.yexcr.2005.03.015", "15925590"]}, {"Citation": "Lee JE. Basic helix-loop-helix genes in neural development. Current opinion in neurobiology. 1997;7:13\u201320. doi: 10.1016/S0959-4388(97)80115-8.", "ArticleIdList": ["10.1016/S0959-4388(97)80115-8", "9039799"]}, {"Citation": "Kageyama R, Ohtsuka T, Tomita K. The bHLH gene Hes1 regulates differentiation of multiple cell types. Molecules and cells. 2000;10:1\u20137. doi: 10.1007/s10059-000-0001-0.", "ArticleIdList": ["10.1007/s10059-000-0001-0", "10774739"]}, {"Citation": "Gratton MO, et al. Hes6 promotes cortical neurogenesis and inhibits Hes1 transcription repression activity by multiple mechanisms. Molecular and cellular biology. 2003;23:6922\u20136935. doi: 10.1128/MCB.23.19.6922-6935.2003.", "ArticleIdList": ["10.1128/MCB.23.19.6922-6935.2003", "PMC193938", "12972610"]}, {"Citation": "Liu W, Li W-M, Gao C, Sun N-L. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. Journal of autoimmunity. 2005;25:258\u2013263. doi: 10.1016/j.jaut.2005.06.005.", "ArticleIdList": ["10.1016/j.jaut.2005.06.005", "16242301"]}, {"Citation": "Ghareghani M, et al. Melatonin exacerbates acute experimental autoimmune encephalomyelitis by enhancing the serum levels of lactate: A potential biomarker of multiple sclerosis progression. Clinical and Experimental Pharmacology and Physiology. 2017;44:52\u201361. doi: 10.1111/1440-1681.12678.", "ArticleIdList": ["10.1111/1440-1681.12678", "27696474"]}, {"Citation": "Simone IL, et al. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques. J Neurol Sci. 1996;144:182\u2013190. doi: 10.1016/S0022-510X(96)00224-9.", "ArticleIdList": ["10.1016/S0022-510X(96)00224-9", "8994122"]}, {"Citation": "Nicoli F, et al. Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy. Comptes rendus de l\u2019Academie des sciences. Serie III, Sciences de la vie. 1996;319:623\u2013631.", "ArticleIdList": ["9011324"]}, {"Citation": "Kim Y, Szele FG. Activation of subventricular zone stem cells after neuronal injury. Cell and tissue research. 2008;331:337\u2013345. doi: 10.1007/s00441-007-0451-1.", "ArticleIdList": ["10.1007/s00441-007-0451-1", "17694326"]}, {"Citation": "Nait-Oumesmar B, et al. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci USA. 2007;104:4694\u20134699. doi: 10.1073/pnas.0606835104.", "ArticleIdList": ["10.1073/pnas.0606835104", "PMC3025281", "17360586"]}, {"Citation": "Chang KA, et al. Therapeutic potentials of neural stem cells treated with fluoxetine in Alzheimer\u2019s disease. Neurochemistry international. 2012;61:885\u2013891. doi: 10.1016/j.neuint.2012.03.017.", "ArticleIdList": ["10.1016/j.neuint.2012.03.017", "22490608"]}, {"Citation": "Hitoshi S, et al. Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress. Journal of neuroscience research. 2007;85:3574\u20133585. doi: 10.1002/jnr.21455.", "ArticleIdList": ["10.1002/jnr.21455", "17668856"]}, {"Citation": "Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2000;20:9104\u20139110.", "ArticleIdList": ["PMC6773038", "11124987"]}, {"Citation": "Louvi A, Artavanis-Tsakonas S. Notch signalling in vertebrate neural development. Nature reviews. Neuroscience. 2006;7:93\u2013102. doi: 10.1038/nrn1847.", "ArticleIdList": ["10.1038/nrn1847", "16429119"]}, {"Citation": "Ohtsuka T, Sakamoto M, Guillemot F, Kageyama R. Roles of the basic helix-loop-helix genes Hes1 and Hes5 in expansion of neural stem cells of the developing brain. The Journal of biological chemistry. 2001;276:30467\u201330474. doi: 10.1074/jbc.M102420200.", "ArticleIdList": ["10.1074/jbc.M102420200", "11399758"]}, {"Citation": "Nakamura Y, et al. The bHLH gene hes1 as a repressor of the neuronal commitment of CNS stem cells. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2000;20:283\u2013293.", "ArticleIdList": ["PMC6774123", "10627606"]}, {"Citation": "Bertrand N, Castro DS, Guillemot F. Proneural genes and the specification of neural cell types. Nature reviews. Neuroscience. 2002;3:517\u2013530. doi: 10.1038/nrn874.", "ArticleIdList": ["10.1038/nrn874", "12094208"]}, {"Citation": "Imayoshi I, Sakamoto M, Yamaguchi M, Mori K, Kageyama R. Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2010;30:3489\u20133498. doi: 10.1523/JNEUROSCI.4987-09.2010.", "ArticleIdList": ["10.1523/JNEUROSCI.4987-09.2010", "PMC6634119", "20203209"]}, {"Citation": "Gerdes J, et al. Journal of immunology (Baltimore, Md.: 1950) 1984. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67; pp. 1710\u20131715.", "ArticleIdList": ["6206131"]}, {"Citation": "Scholzen, T. & Gerdes, J. The Ki-67 protein: from the known and the unknown. Journal of cellular physiology182, 311\u2013322, doi:10.1002/(sici)1097-4652 (2000).", "ArticleIdList": ["10653597"]}, {"Citation": "Browning WN. Exacerbation of symptoms of multiple sclerosis in a patient taking fluoxetine. The American journal of psychiatry. 1990;147:1089.", "ArticleIdList": ["2375445"]}, {"Citation": "Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of consulting and clinical psychology. 2001;69:942\u2013949. doi: 10.1037/0022-006X.69.6.942.", "ArticleIdList": ["10.1037/0022-006X.69.6.942", "11777121"]}, {"Citation": "Baldessarini RJ, Marsh E. Fluoxetine and side effects. Archives of general psychiatry. 1990;47:191\u2013192. doi: 10.1001/archpsyc.1990.01810140091015.", "ArticleIdList": ["10.1001/archpsyc.1990.01810140091015", "2105706"]}, {"Citation": "Dalery J, Honig A. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison. Human psychopharmacology. 2003;18:379\u2013384. doi: 10.1002/hup.490.", "ArticleIdList": ["10.1002/hup.490", "12858325"]}, {"Citation": "Balkowiec-Iskra E, et al. MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice. Inflammation research: official journal of the European Histamine Research Society\u2026 [et al.] 2007;56:311\u2013317. doi: 10.1007/s00011-007-6128-0.", "ArticleIdList": ["10.1007/s00011-007-6128-0", "17687515"]}, {"Citation": "Lieberknecht, V. et al. Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice. Molecular neurobiology, doi:10.1007/s12035-016-9717-5 (2016).", "ArticleIdList": ["26801190"]}, {"Citation": "Abdel-Salam OM, Baiuomy AR, Arbid MS. Studies on the anti-inflammatory effect of fluoxetine in the rat. Pharmacological research. 2004;49:119\u2013131. doi: 10.1016/j.phrs.2003.07.016.", "ArticleIdList": ["10.1016/j.phrs.2003.07.016", "14643692"]}, {"Citation": "Wingerchuk DM, Lucchinetti CF, Noseworthy JH. Multiple Sclerosis: Current Pathophysiological Concepts. Lab Invest. 2001;81:263\u2013281. doi: 10.1038/labinvest.3780235.", "ArticleIdList": ["10.1038/labinvest.3780235", "11310820"]}, {"Citation": "Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annual review of immunology. 1997;15:297\u2013322. doi: 10.1146/annurev.immunol.15.1.297.", "ArticleIdList": ["10.1146/annurev.immunol.15.1.297", "9143690"]}, {"Citation": "Del Prete G, Maggi E, Romagnani S. Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab Invest. 1994;70:299\u2013306.", "ArticleIdList": ["8145524"]}, {"Citation": "Gordon GR, Mulligan SJ, MacVicar BA. Astrocyte control of the cerebrovasculature. Glia. 2007;55:1214\u20131221. doi: 10.1002/glia.20543.", "ArticleIdList": ["10.1002/glia.20543", "17659528"]}, {"Citation": "Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain research bulletin. 1999;49:377\u2013391. doi: 10.1016/S0361-9230(99)00072-6.", "ArticleIdList": ["10.1016/S0361-9230(99)00072-6", "10483914"]}, {"Citation": "Chen ZJ, Negra M, Levine A, Ughrin Y, Levine JM. Oligodendrocyte precursor cells: reactive cells that inhibit axon growth and regeneration. Journal of neurocytology. 2002;31:481\u2013495. doi: 10.1023/A:1025791614468.", "ArticleIdList": ["10.1023/A:1025791614468", "14501218"]}, {"Citation": "Bundesen LQ, Scheel TA, Bregman BS, Kromer LF. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2003;23:7789\u20137800.", "ArticleIdList": ["PMC6740614", "12944508"]}, {"Citation": "Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000) Neurochemical research. 2000;25:1439\u20131451. doi: 10.1023/A:1007677003387.", "ArticleIdList": ["10.1023/A:1007677003387", "11059815"]}, {"Citation": "Robel S, Berninger B, Gotz M. The stem cell potential of glia: lessons from reactive gliosis. Nature reviews. Neuroscience. 2011;12:88\u2013104. doi: 10.1038/nrn2978.", "ArticleIdList": ["10.1038/nrn2978", "21248788"]}, {"Citation": "Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Yong VW. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1994;14:846\u2013856.", "ArticleIdList": ["PMC6576825", "8301364"]}, {"Citation": "Nash B, Ioannidou K, Barnett SC. Astrocyte phenotypes and their relationship to myelination. Journal of Anatomy. 2011;219:44\u201352. doi: 10.1111/j.1469-7580.2010.01330.x.", "ArticleIdList": ["10.1111/j.1469-7580.2010.01330.x", "PMC3130159", "21496013"]}, {"Citation": "Blakemore WF. The response of oligodendrocytes to chemical injury. Acta neurologica Scandinavica. Supplementum. 1984;100:33\u201338.", "ArticleIdList": ["6385605"]}, {"Citation": "Talbott JF, et al. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Experimental neurology. 2005;192:11\u201324. doi: 10.1016/j.expneurol.2004.05.038.", "ArticleIdList": ["10.1016/j.expneurol.2004.05.038", "PMC2813490", "15698615"]}, {"Citation": "Graca DL, Blakemore WF. Delayed remyelination in rat spinal cord following ethidium bromide injection. Neuropathology and applied neurobiology. 1986;12:593\u2013605. doi: 10.1111/j.1365-2990.1986.tb00162.x.", "ArticleIdList": ["10.1111/j.1365-2990.1986.tb00162.x", "3561693"]}, {"Citation": "Wensky AK, et al. IFN- Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis. The Journal of Immunology. 2005;174:1416\u20131423. doi: 10.4049/jimmunol.174.3.1416.", "ArticleIdList": ["10.4049/jimmunol.174.3.1416", "15661899"]}, {"Citation": "Butovsky O, et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. Journal of Clinical Investigation. 2006;116:905\u2013915. doi: 10.1172/JCI26836.", "ArticleIdList": ["10.1172/JCI26836", "PMC1409740", "16557302"]}, {"Citation": "Zhang J, et al. Targeting oligodendrocyte protection and remyelination in multiple sclerosis. The Mount Sinai journal of medicine, New York. 2011;78:244\u2013257. doi: 10.1002/msj.20244.", "ArticleIdList": ["10.1002/msj.20244", "PMC3074606", "21425268"]}, {"Citation": "Mason JL, et al. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. Journal of neuroscience research. 2000;61:251\u2013262. doi: 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W.", "ArticleIdList": ["10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W", "10900072"]}, {"Citation": "Pang Y, Zheng B, Fan L-W, Rhodes PG, Cai Z. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway. Glia. 2007;55:1099\u20131107. doi: 10.1002/glia.20530.", "ArticleIdList": ["10.1002/glia.20530", "17577243"]}, {"Citation": "Ye P, Li L, Richards RG, DiAugustine RP, D\u2019Ercole AJ. Myelination Is Altered in Insulin-Like Growth Factor-I Null Mutant Mice. The Journal of Neuroscience. 2002;22:6041\u20136051.", "ArticleIdList": ["PMC6757955", "12122065"]}, {"Citation": "Oreja-Guevara C, Ramos-Cejudo J, Aroeira LS, Chamorro B, Diez-Tejedor E. TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab. BMC neurology. 2012;12:95\u201395. doi: 10.1186/1471-2377-12-95.", "ArticleIdList": ["10.1186/1471-2377-12-95", "PMC3517482", "22989378"]}, {"Citation": "Soos JM, et al. Astrocytes Express Elements of the Class II Endocytic Pathway and Process Central Nervous System Autoantigen for Presentation to Encephalitogenic T Cells. The Journal of Immunology. 1998;161:5959\u20135966.", "ArticleIdList": ["9834077"]}, {"Citation": "Nikcevich KM, et al. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. The Journal of Immunology. 1997;158:614\u2013621.", "ArticleIdList": ["8992975"]}, {"Citation": "Liu D, et al. Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells. Neuropharmacology. 2011;61:592\u2013599. doi: 10.1016/j.neuropharm.2011.04.033.", "ArticleIdList": ["10.1016/j.neuropharm.2011.04.033", "21575647"]}, {"Citation": "Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. American journal of physiology. Regulatory, integrative and comparative physiology. 2004;287:R502\u2013516. doi: 10.1152/ajpregu.00114.2004.", "ArticleIdList": ["10.1152/ajpregu.00114.2004", "15308499"]}, {"Citation": "Amorini AM, et al. Serum lactate as a novel potential biomarker in multiple sclerosis. Biochimica et biophysica acta. 2014;1842:1137\u20131143. doi: 10.1016/j.bbadis.2014.04.005.", "ArticleIdList": ["10.1016/j.bbadis.2014.04.005", "24726946"]}, {"Citation": "Ghareghani M, et al. Methylprednisolone improves lactate metabolism through reduction of elevated serum lactate in rat model of multiple sclerosis. Biomedicine & Pharmacotherapy. 2016;84:1504\u20131509. doi: 10.1016/j.biopha.2016.11.042.", "ArticleIdList": ["10.1016/j.biopha.2016.11.042", "27884750"]}, {"Citation": "Tress O, et al. Panglial gap junctional communication is essential for maintenance of myelin in the CNS. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2012;32:7499\u20137518. doi: 10.1523/JNEUROSCI.0392-12.2012.", "ArticleIdList": ["10.1523/JNEUROSCI.0392-12.2012", "PMC6703577", "22649229"]}, {"Citation": "Hirrlinger J, Dringen R. The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. Brain research reviews. 2010;63:177\u2013188. doi: 10.1016/j.brainresrev.2009.10.003.", "ArticleIdList": ["10.1016/j.brainresrev.2009.10.003", "19883686"]}, {"Citation": "Funfschilling U, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012;485:517\u2013521.", "ArticleIdList": ["PMC3613737", "22622581"]}, {"Citation": "Lee Y, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443\u2013448. doi: 10.1038/nature11314.", "ArticleIdList": ["10.1038/nature11314", "PMC3408792", "22801498"]}, {"Citation": "Rinholm JE, Bergersen LH. White matter lactate\u2013does it matter? Neuroscience. 2014;276:109\u2013116. doi: 10.1016/j.neuroscience.2013.10.002.", "ArticleIdList": ["10.1016/j.neuroscience.2013.10.002", "24125892"]}, {"Citation": "Remington LT, Babcock AA, Zehntner SP, Owens T. Microglial Recruitment, Activation, and Proliferation in Response to Primary Demyelination. The American Journal of Pathology. 2007;170:1713\u20131724. doi: 10.2353/ajpath.2007.060783.", "ArticleIdList": ["10.2353/ajpath.2007.060783", "PMC1854965", "17456776"]}, {"Citation": "Azari, H., Sharififar, S., Rahman, M., Ansari, S. & Reynolds, B. A. Establishing embryonic mouse neural stem cell culture using the neurosphere assay. J Vis Exp, doi:10.3791/2457 (2011).", "ArticleIdList": ["PMC3182648", "21248704"]}, {"Citation": "Ghareghani, M. et al. Melatonin Increases Oligodendrocyte Differentiation in Cultured Neural Stem Cells. Cellular and Molecular Neurobiology, doi:10.1007/s10571-016-0450-4 (2016).", "ArticleIdList": ["27987059"]}, {"Citation": "Mitchell KM, et al. Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13:1118\u20131126. doi: 10.1177/1352458507078916.", "ArticleIdList": ["10.1177/1352458507078916", "17967839"]}, {"Citation": "Dalle E, Daniels WM, Mabandla MV. Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression. Behavioural brain research. 2017;316:189\u2013196. doi: 10.1016/j.bbr.2016.08.005.", "ArticleIdList": ["10.1016/j.bbr.2016.08.005", "27569183"]}, {"Citation": "Hajhashemi V, Sadeghi H, Minaiyan M, Movahedian A, Talebi A. Effect of Fluvoxamine on Carrageenan-Induced Paw Edema in Rats Evaluation of the Action Sites. Iranian Journal of Pharmaceutical Research: IJPR. 2011;10:611\u2013618.", "ArticleIdList": ["PMC3813036", "24250395"]}, {"Citation": "Artiss JD, et al. A Liquid-Stable Reagent for Lactic Acid Lsevels. American Journal of Clinical Pathology. 2000;114:139. doi: 10.1309/65UJ-FQ75-DVGC-XX1N.", "ArticleIdList": ["10.1309/65UJ-FQ75-DVGC-XX1N", "10884809"]}]}], "History": [{"Year": "2017", "Month": "4", "Day": "6"}, {"Year": "2017", "Month": "5", "Day": "22"}, {"Year": "2017", "Month": "7", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["28687730", "PMC5501834", "10.1038/s41598-017-04968-z", "10.1038/s41598-017-04968-z"]}}]}